Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

BackBeat Cardiac Neuromodulation Therapy Shows Immediate, Substantial Blood Pressure Reduction
News | Hypertension | June 04, 2019

June 4, 2019 — Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato...

Hypertension Found in Children Exposed to Flower Pesticides
News | Congenital Heart | June 03, 2019

June 3, 2019 — Researchers at University of California San Diego School of Medicine found...

Philips Shares Three-Year Results for Stellarex .035 Drug-Coated Balloon
News | Drug-Eluting Balloons | May 29, 2019

May 29, 2019 — Philips announced the three-year results from the ILLUMENATE Pivotal trial and the ILLUMENATE...

HeartFlow Planner Changes Treatment Strategy for Coronary Heart Disease Patients
News | CT Angiography (CTA) | May 28, 2019

May 28, 2019 — New data demonstrated that use of the investigational HeartFlow Planner, a real-time, non-invasive...

Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019

May 23, 2019 — People who skip breakfast and eat dinner near bedtime have...

Medtronic Presents Positive Renal Denervation Results at EuroPCR 2019
News | Renal Denervation | May 23, 2019

May 23, 2019 – Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored...

Illustration showing the catheter steps for the LAMPOON procedure designed to prevent left ventricular outflow tract (LVOT) obstruction . From Dr. Jaffar M. Khan and the Laboratory of Cardiovascular Intervention, led by Dr. Robert J. Lederman.

Figure 1: Illustration showing the catheter steps for the LAMPOON procedure. From Dr. Jaffar M. Khan and the Laboratory of Cardiovascular Intervention, led by Dr. Robert J. Lederman.

Feature | Heart Valve Technology | May 22, 2019

Researchers at the National, Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (...

New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019

May 17, 2019 — Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b...

Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019

May 16, 2019 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro...

CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019

May 16, 2019 — CardioFocus Inc. announced the presentation of results from its...

HRS 2019 late breaking trials, late breaking presentations for the biggest news in electrophysiology (EP). #HRS #HRS2019 #HRS19
Feature | HRS | May 15, 2019 | Dave Fornell, Editor

May 15, 2019 — The Heart Rhythm Society (HRS) had 21 late-...

Electromechanical Wave Imaging (EWI) is a new, high-frame rate 3-D rendered ultrasound technique that can noninvasively map the electromechanical activation of heart rhythm. This example shows the ECG tracings compared to the EWI image of the heart.

Electromechanical Wave Imaging (EWI) is a new, high-frame rate 3-D rendered ultrasound technique that can noninvasively map the electromechanical activation of heart rhythm. This example shows the ECG tracings compared to the EWI image of the heart.

Feature | EP Mapping and Imaging Systems | May 15, 2019 | Dave Fornell, Editor

May 15, 2019 — A new study shows electromechanical wave imaging is capable of localizing arrhythmias including...

A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.

Figure 1: The PADIT infection risk score ranging from 0 to 14 points classified patients into three risk groups, low (0-4), intermediate (5-6) and high (≥7). The risk groups had rates of hospitalization for infection of 0.51%, 1.42% and 3.41%, respectively 

News | EP Lab | May 15, 2019

May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1]...

Overlay Init